Importantly, inhibition of ER signalling, which suppresses ER-positive breast cancer cell growth, decreased the expression of both Cdc6 and Cdt1 in vitro and in human breast cancer specimens, while lower expression of Cdc6 correlated with a better response of the tumour towards inhibition of ER signalling. The gene discussed is CDT1; the disease is neoplasm.